Viewing Study NCT03702933


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-03-03 @ 3:05 PM
Study NCT ID: NCT03702933
Status: UNKNOWN
Last Update Posted: 2018-10-11
First Post: 2018-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: D-serine in Schizophrenia
Sponsor: Herzog Hospital
Organization:

Study Overview

Official Title: The Effects of Add-On D-serine Pharmacotherapy in Chronic Treatment Resistant Schizophrenia Patients
Status: UNKNOWN
Status Verified Date: 2018-10
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DSRSZ
Brief Summary: This study will assess the effects of D-serine adjuvant treatment to the ongoing pharmacological treatment of schizophrenia patients that are resistant to treatments.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: